Company: BDJ
Filing Date: 2025-03-07
Form Type: N-CSR
Source: 0001193125-25-049575
Chunk: 14

Company: BlackRock Enhanced Equity Dividend Trust
Filing Date: 2025-03-07
Form: N-CSR
Chunk 14
---
 performance as clinical trial results for weight loss drug CagriSema failed to represent an advance over Eli Lilly’s existing entry. While this outcome has hurt the optics around Novo Nordisk’s competitive position versus Eli-Lilly, the two companies are expected to dominate the obesity treatment market for the foreseeable future, and additional CagriSema data is expected early in 2025. The Trust utilized an options overlay strategy in which calls are written on a portion of the portfolio ’ s holdings. The Trust ’ s options overlay strategy detracted from relative performance for the period. The Trust’s practice of maintaining a speciﬁed level of monthly distributions to shareholders did not have a material impact on the Trust’s investment strategy. The distribution policy resulted in return of capital for the period. Refer to the financial highlights and income tax information sections in this report for further information about the distributions. Describe recent portfolio activity. During the reporting period, the Trust added exposure to the industrials, healthcare and consumer staples sectors. The Trust reduced exposure to information technology, communication services and consumer discretionary.

Trust Summary 13

Trust Summary as of December 31, 2024 (continued) BlackRock Enhanced Global Dividend Trust (BOE) Describe portfolio positioning at period end. At the end of the period, the Trust’s largest sector overweights were to industrials, healthcare and consumer staples. Regionally, the majority of the portfolio was listed in the United States, with significant exposure in Europe. As of December 31, 2024, the Trust had in place an option overwriting program whereby 43.6% of the underlying equities were overwritten with call options on individual stocks. These call options were typically written at prices above the prevailing market prices (estimated to be 3.0% out of the money) and for maturities averaging 60 days. The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions.
These views are not intended to be a forecast of future events and are no guarantee of future results. Overview of the Trust’s Total Investments

| TEN LARGEST HOLDINGS                        |                                |
| Security                                    | Percent of TotalInvestments(a) |
| Microsoft Corp.                             |                           4.8% |
| Taiwan Semiconductor Manufacturing Co. Ltd. |                            3.5 |
| Accenture PLC                               |                            3.2 |
| Broadcom, Inc.                              |                            3.1